THOR reactor
by Yi-Wei Chen
Since 2010, members of THOR (Tsing-Hua Open Pool Reacher Reactor) start to collaborate with the medical group of Taipei Veterans General Hospital for clinical BNCT use in Taiwan. Up to now (October 2024), near 500 patients, including clinical trials and compassionate use, underwent BNCT for salvage purpose. Most of them were recurrent brain tumor and recurrent head & neck cancer cases. We hope BNCT in Taiwan can become a standard cancer treatment soon in the near future.
We also received several global patients and the treatment outcomes of them were satisfied.
Bennu® accelerator-based BNCT system
by Wei-Lin Chen
An accelerator-based BNCT system – Bennu® – was installed at China Medical University Hospital, Hsinchu, and became operational in 2024. The system was designed and manufactured in Taiwan by Heron Neutron Medical Corp., and was approved by the Taiwan Food and Drug Administration (TFDA) in June 2024.
The center provides BNCT treatment under both clinical trial and compassionate use programs, and has treated several international cases to date. In addition, collaborative clinical trials and compassionate use programs are ongoing in partnership with Taipei Veterans General Hospital, one of Taiwan’s leading medical centers.
Clinical trial
Completed Phase I/II – Recurrent meningioma (ClinicalTrials.gov)
Ongoing Phase II – Recurrent head and neck cancer (ClinicalTrials.gov)
Ongoing Phase I/II – Malignant brain tumors (ClinicalTrials.gov)
Contact
More information
If you need more information, please contact us !